LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that Michael G. Kauffman, M.D., Ph.D., chief executive officer of EPIX, is scheduled to participate in a session entitled, “Effective Global Clinical Trial Design: Case Studies and Panel Discussion” at the Neurotech Industry Investing and Partnering Conference at the Westin Copley Place in Boston on Friday, May 9, 2008 at 10:45 a.m. (ET).
